Efficacy of Non-instrumental Pleural Chest Physiotherapy
France82 participantsStarted 2019-06-06
Plain-language summary
The main purpose of this study is to assess efficacy of non instrumental pleural chest physiotherapy on the recovery of respiratory function, at hospital discharge or 15 days after beginning the pleural chest physiotherapy, compared to physiotherapy with standard mobilization, in patients with infectious pleural effusion, who have received usual medical treatment.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* ≥ eighteen years old
* to be hospitalized for an infectious pleural outpouring
* to have a liquid pleural outpouring diagnosed by echography or to scan thoracic
* presence of a Exudate according to the criteria of Light, to have at least criteria:
* The ratio of pleural fluid protein to serum protein is greater than 0.5
* The ratio of pleural fluid Lactate dehydrogenase (LDH) and serum LDH is greater than 0.6
* The rate of pleural fluid LDH is \> 2/3 upper limit of normal serum LDH of the laboratory concerned
* presence of at least two of the following criteria:
* fever higher or equal 38°C (100.4°F)
* thoracic pain
* purulent sputum
* purulent pleural effusion at the time of the exploring pleural puncture
* hearth of crackling to the sounding
* Inflammatory syndrome (CRP\>15 mg/l and/or White blood cell \>10 000 /mm3)
* no known radiological hearth before
* Having undergone an evacuation gesture going back to less forty-eight hours: evacuation pleural puncture or repeated pleural punctures or pleural drainage allowing the evacuation of at least 100cc of pleural fluid
* Informed and having given its free, lit and express assent
* Patients with affiliation to the social security system
Exclusion Criteria:
* Patient having undergone a thoracotomy or thoracoscopy in the six previous months
* Patient having a pneumothorax
* Patient reached of a tuberculosis
* Patient unable to carry out a measurement of the vital capacity by portable…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Variation of vital capacity theoretical between the first day of inclusion and J15 or the last day of hospitalization
Timeframe: At 15 days after inclusion or the last day of hospitalization